Status
Conditions
Treatments
About
INTRODUCTION AND RATIONALE
It has been estimated that at least 50% of the home living persons with dementia in the Netherlands receive little or no formal care and support (Zorgstandaard Dementie, 2013). Reasons why persons with dementia and their informal caregivers receive no formal care vary, include absence of diagnosis, denial of illness, embarrassment or the complexity of the care and referral system. A common concern among health care professionals is that by the time the person with dementia or informal caregiver do seek or receive formal care it may be too late. The difficulties at home may already be so severe that there is little that community-based care can do and admission to residential care may follow soon after. Appropriate support at an earlier stage may prevent more serious difficulties and postpone admission to residential care. Therefore, health care professionals are looking for strategies to reach persons with dementia and caregivers in an earlier stage of dementia and encourage them to accept some form of help or support. The rationale of this study is to investigate how persons living with dementia and their close others can be encouraged to accept support and whether support at an early stage is effective in preventing severe deterioration in wellbeing, behavioural difficulties and high care costs later on.
OBJECTIVES
STUDY DESIGN
Pragmatic, cluster randomised controlled trial.
STUDY POPULATION
Informal caregivers and people with early-stage dementia, who are community dwelling and receive little or no dementia-related formal ADL care.
INTERVENTION
The intervention (Eerder Erbij, EE) is a person-centred, manual-based intervention consisting of education, information and a support group.
MAIN STUDY PARAMETERS/ENDPOINTS
Primary: self-efficacy. Cost-utility: EQ5D, RUD. Secondary: quality-of-life, caregiver burden.
DATA COLLECTION
Measurements consist of questionnaires (total duration is approximately 1 hour; administered at home; take place at baseline, 3, 6, and 12 months).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
102 participants in 2 patient groups
Loading...
Central trial contact
Sanne Balvert, Msc.; Maarten Milders, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal